HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia

Virology Journal

Volumn 10, Issue , 2013, Pages

  Wondimeneh, Yitayih ^a   Alem, Meseret ^a   Asfaw, Fanaye ^a   Belyhun, Yeshambel ^a,b  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

CD4 T cells; HBV; HCV; HIV; Liver enzymes

Indexed keywords

CD4 ANTIGEN; LIVER ENZYME;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; SEROLOGY; SEROPREVALENCE; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HOSPITALS, TEACHING; HUMANS; LIVER; MALE; MIDDLE AGED; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; TRANSAMINASES; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84878264508     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-171     Document Type: Article

References (53)

1. The natural history of Hepatitis C Virus (HCV) infection. Chen LS, Morgan RT, Int J Med Sci 2006 3 2 48 59
2. The changing global epidemiology of HBV and HCV. Fenton K, Frontiers in Drug Development for Viral Hepatitis 2007 3 3 4
3. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, J Hepatol 2005 42 5 615 624 10.1016/j.jhep.2005.03.003 15916745
4. A survey of hepatitis B and C prevalence among the homeless community of parague. Volf V, Marx D, Pliscova L, Sumega L, Celko A, Eur J Public Health 2008 18 44 47 10.1093/eurpub/ckm072 17613558
5. Management of chronic hepatitis B and C in HIV-coinfected patients. Soriano V, Barreiro P, Nunez M, J Antimicrob Chemother 2006 57 815 818 10.1093/jac/dkl068 16556638
6. HIV/AIDs and hepatitis C Co-infection. Sharifi-Mood B, Metanat M, Int J Virol 2006 2 1 63 66
7. Viral hepatitis in HIV infection. Koziel M, Peters M, New England Medical Journal 2007 356 14 1445 1454 10.1056/NEJMra065142
8. Hepatitis B and HIV Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, AIDS 2005 19 593 601 10.1097/01.aids.0000163936.99401.fe 15802978
9. HIV and hepatitis C co infection within the CAESAR study. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ, HIV Med 2004 5 174 179 10.1111/j.1468-1293.2004.00207.x 15139984
10. Hepatitis B/C and HIV in sub-Saharan Africa. Barth E, Quirine H, Jantjie T, Hoepelman I, Int J Infect Dis 2010 14 12 1024 1031 10.1016/j.ijid.2010.06.013
11. Viral hepatitis and HIV co-infection. Sulkowski M, Journal of Hepathology 2008 48 2 353 367 10.1002/hep.22407
12. HIV/HCV co-infection, histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment. Petrovic L, Liver Int 2007 27 598 606 10.1111/j.1478-3231.2007.01478.x 17498243
13. HIV/HBV and HIV/HCV co-infection and outcomes following highly active antiretroviral therapy. Lincoln D, Petoumenos K, Dore G, HIV Med 2003 4 241 249 10.1046/j.1468-1293.2003.00152.x 12859323
14. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS, Hanson D, Teshale E, Wotring L, Brooks J, AIDS 2006 20 1171 1179 10.1097/01.aids.0000226958.87471.48 16691069
15. Hepatitis C and progression of HIV disease. Sulkowski M, Moore R, Mehta S, Chaisson R, Thomas D, J Am Med Assoc 2002 288 199 206 10.1001/jama.288.2.199
16. The impact of human immunodeficiency virus on viral hepatitis. Mallet V, Vallet-Pichard A, Pol S, Liver Int 2011 31 1 135 139 21205151
17. Hepatitis B and human immunodeficiency virus coinfection. Thio CL, Hepathology 2009 49 5 138 145
18. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. Romeo R, Rumi M, Donato M, Cargne P, Vigano M, Mondelli B, Journal of Viral Hepathology 2000 7 297 301 10.1046/j.1365-2893.2000.00230.x
19. Christian B, Okuma J, Claudia H, Chalamilla G, Spiegelman D, Nagu T, Prevalence of hepatitis B and C Co-infection and response to antiretroviral therapy among HIV-infected patients in an urban setting in Tanzania California: 17th Conference on Retroviruses & Opportunistic Infections in San Francisco 2010
20. Hepatitis B virus and hepatitis C virus Co-infection with HIV patients at khon kaen hospital. Leeratanapetch N, Suseangrut W, Khon Kaen Hospital Medical Journal 2008 32 229 238
21. Viral hepatitis and HIV in Africa. Modi A, Feld J, AIDS Review 2007 9 25 39
22. Hepatitis C and B viruses: the new opportunists in HIV infection. Chung R, Tropical HIV Medicine 2006 14 2 78 83
23. Seroprevalence of HIV, hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia. Moges F, Kebede Y, Kassu A, Mulu A, Tiruneh M, Degu G, Ethiop J Heal Dev 2006 20 3 5
24. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University teaching hospital Northwest Ethiopia. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, BMC Infect Dis 2010 10 111 4 5 20055991
25. Blood safety & prevalence of transfusion transmissible viral infections among donors at the Red cross blood bank in Gondar University hospital. Diro E, Alemu S, Alemu S, G/Yohannes A, Ethiop Med J 2008 46 1 7 13 18711984
26. Ethiopian Federal Ministry of Health, Guidelines for management of opportunistic infections and anti-retroviral treatment in adolescents and adults in Ethiopia Addis Ababa Ethiopia: Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health 2008
27. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Lesi O, Kehinde M, Oguh D, Amira C, Niger Postgrad Med J 2007 14 129 133 17599111
28. Prevalence of infection with hepatitis B and C virus and co-infection with HIV in medical inpatients in Malawi. Nyirenda M, Beadsworth M, Stephany P, Hart C, Hart I, Munthali C, J Infect Dis 2008 57 72 77
29. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India. Hussain T, Kulshreshtha KK, Sinha S, Yadav VS, Katoch VM, Int J Infect Dis 2006 10 5 358 363 10.1016/j.ijid.2005.09.005 16678462
30. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P, Ann Hepatol 2008 7 2 152 156 18626434
31. Hepatitis C virus Co-infection in human immuno deficiency virus positive population in bida, north central Nigeria. Omosigho OP, Inyinbor HE, Emumwen GE, Mohammed SK, Ledogo G, Njab J, Oladejo OP, Omueti EA, The Internet Journal of Infectious Diseases 2011 9 2
32. Epidemiology of viral hepatitis and HIV co-infection. Alter M, Journal of Hepathology 2006 44 6 9 10.1002/hep.21269
33. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus. Sherman K, Rouster S, Chung R, Rajicic N, Clin Infect Dis 2002 34 831 837 10.1086/339042 11833007
34. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly antiretroviral therapy. Rockstroh J, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, J Infect Dis 2005 192 992 1002 10.1086/432762 16107951
35. Hepatitis B and C virus infections and liver function in AIDS patients at Chrishanibaragwanath hospital Johannesburg. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I, East African Medical January 2000 77 1 13 15
36. Toxoplasma gondii, HCV, and HBV seroprevalence and Co-infection among HIV positive and negative pregnant women in Burkina Faso. Simpore J, Savadogo A, Ilboudo D, Nadambega C, Esposito M, Yara J, J Med Virol 2006 78 730 733 10.1002/jmv.20615 16628587
37. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H, Toure'-Kane C, Etard JF, Lo G, Diaw PA, Ngom-Gueye NF, J Med Virol 2008 80 1332 1336 10.1002/jmv.21236 18551596
38. Prevalence of markers of infection with hepatitis B and C viruses in immigrants of operation Solomon, 1991. Flatau E, Segol O, Shneour A, Tabenkin H, Raz R, Isr J Med Sci 1993 29 6-7 387 389 8394300
39. A survey of antibodies to HCV in Ethiopia. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F, AmJTrop Med Hyg 1993 49 4 435 439
40. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Tsegaye E, Nordenfelt E, Hansson BG, Trans R Soc Trop Med Hyg 1995 89 2 171 174 10.1016/0035-9203(95)90482-4 7539952
41. Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. Ayele W, Nokes J, Abebe A, Messele T, Dejene A, Enquselassie F, J Med Virol 2002 68 12 17 10.1002/jmv.10164 12210425
42. Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. Dessie A, Abera B, Wale F, Ethiop J Health Dev 2007 21 1 68 69
43. Higher prevalence of anti HCV antibodies among HIV positive compared to HIV negative inhabitants of Addis Ababa Ethiopia. Ayele Ayele W, Nokes DJ, Abebe A, Messele T, Dejene A, Enquselassie F, Rinke de Wit FT, Fontanet LA, J Med Virol 2002 68 12 17 10.1002/jmv.10164 12210425
44. Genotypes and viral load of HCV among persons attending a VCT center in Ethiopia. Abreha T, Woldeamanuel Y, Pietsch C, Maier M, Asrat D, Abebe A, Hailegiorgis B, Aseffa A, Liebert UG, J Med Virol 10.1002/jmv.21788
45. Prevalence and risk factors of hepatitis C among individuals presenting to HIV testing centers, hawassa city southern Ethiopia. Alemayehu A, Tassachew Y, Sisay Z, Shimelis T, BMC Research Notes 2011 4 193 10.1186/1756-0500-4-193 21676227
46. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. Olufemi A, Emmanuel A, Zaccheus A, Ibrahim W, Funmilayo E, Patience A, Journal of Infectious DevCtries 2009 3 5 369 375
47. High prevalence of HBV, HCV, and HIV infections in gypsy population residing in Shahr-E-Kord. Kazem S, Asl H, Avijgan M, Mohamadnejad M, Arch Iranian Medicine 2004 7 1 20 22
48. Fuse V, Cornelio C, Meraldi N, Prevalence of HCV and HBV in HIV positive patients attending a general hospital in Buenos Aires International Conference of AIDS: Argentina 2004
49. Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: seroprevalence and associated factors. Ataei B, Tayeri K, Kassaian N, Hepatitis Monthly summer 2010 10 3 188 192
50. Low prevalence of hepatitis B virus and hepatitis C virus Co-infection in patients with human immunodeficiency virus in northern India. Tripathi A, Khanna M, Gupta N, Chandra M, Indian Journal of Physicians Association 2007 55 430
51. Identification and quantitation of HIV-1 in the liver of patients with AIDS. Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD, AIDS 1992 6 65 70 10.1097/00002030-199201000-00008 1543567
52. CD4 Count pattern and demographic distribution of treatment-Nȧve HIV patients in Lagos, Nigeria. Akinsegun A, Adedoyin D, Adewumi A, Sarah A, Olajumoke Oshinaike KW, AIDS Research and Treatment 2012 2012 1 6
53. Hematological reference ranges among healthy Ugandans. Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, Mangeni FW, Clin Diagn Lab Immunol 1995 2 2 233 235 7697535